| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 2 |
| 1 | FLUOROURACIL | 2 |
| 2 | FLUOROURACIL CREAM, 0.5% | 2 |
| 3 | NILOTINIB | 2 |
| 4 | PACLITAXEL | 2 |
| 5 | ADALIMUMAB | 1 |
| 6 | ADALIMUMAB-AATY | 1 |
| 7 | ADALIMUMAB-ADAZ | 1 |
| 8 | ADALIMUMAB-FKJP | 1 |
| 9 | BOSUTINIB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NADOFARAGENE FIRADENOVEC-VNCG | 1 | 0.0019 |
| 1 | BOSUTINIB | 1 | 0.0001 |
| 2 | NILOTINIB | 2 | 0.0001 |
| 3 | MERCAPTOPURINE | 1 | 0.0001 |
| 4 | ERGOCALCIFEROL | 1 | 0.0000 |
| 5 | FLUOROURACIL CREAM, 0.5% | 2 | 0.0000 |
| 6 | FLUOROURACIL | 2 | 0.0000 |
| 7 | ADALIMUMAB-FKJP | 1 | 0.0000 |
| 8 | ADALIMUMAB-AATY | 1 | 0.0000 |
| 9 | PACLITAXEL | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 1 | Microtubule Inhibitor [EPC] | 3 | 0.0000 |
| 2 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 5 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |
| 6 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 7 | Fluoroquinolone Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 1 | 0.0000 |